Skip to main content
2026 CRT Conference Main banner

CRT 2026

Early Career Leader Symposium

Session:: Early Career Leader Roundtable [Non-CME; Invitation Only] – Sponsored by Medtronic

Breakout Group Discussion | Clinical Research and Writing

Monday, March 9, 2026
7:00 PM - 7:25 PM EST
Location: Lincoln

    Facilitator(s)

  • SB

    Sandeep Brar, MD

    Sr. Director, Clinical Research
    Medtronic
    Santa Rosa, California, United States

    Disclosure information not submitted.

  • Harold L. Dauerman, MD

    Professor of Medicine
    University of Vermont College of Medicine
    Burlington, Vermont, United States

    Disclosure(s): medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

  • Manuela Negoita, MD

    Vice President SH&A Clinical Research and Medical Science
    Medtronic
    Santa Rosa, California, United States

    Disclosure information not submitted.

  • Robert W. Yeh, MD, MSc

    Professor of Medicine
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts, United States

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)

    • Roundtable Participant(s)

  • Ali Aldujeli, MD., MSc, PhD., MHEM, FESC, FSCAI, FHFA

    Clinical Lead of General and Interventional Cardiology
    Bon Secours Hospital Limerick
    Limerick , Limerick, Ireland

    Disclosure(s): No financial relationships to disclose

  • Michel T. Corban, MD

    Interventional and Structural Cardiologist
    University of Arizona College of Medicine -Tucson / Banner University Medical Center Tucson

    Disclosure(s): Philips Inc: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Priyanka Ghosh, DO

    Interventional & Structural Cardiologist
    AnMed Medical Center
    Anderson, South Carolina, United States

    Disclosure(s): No financial relationships to disclose

  • Joseph Ingrassia, MD

    Interventional Cardiologist / Director Endovascular Intervention / Co- Director PERT
    Hartford Healthcare Heart & Vascular Institute

    Disclosure(s): Inquis Medical: Consulting Fees (e.g., advisory boards) (Terminated, January 14, 2026); Jupiter Medical: Consulting Fees (e.g., advisory boards) (Terminated, January 14, 2026)

  • Arav Jhand, MD

    Interventional and Structural Cardiologist
    Geisinger Medical Center
    Danville, Pennsylvania, United States

    Disclosure(s): No financial relationships to disclose

  • Katherine Lee Chuy, MD

    Interventional Cardiologist
    Carondelet Medical Group

    Disclosure(s): Alnylam Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • Nidhi Madan, MD, MPH, FACC, FSCAI

    Structural Interventional Cardiologist
    Bassett Medical Center
    Cooprestown, New York, United States

    Disclosure(s): No financial relationships to disclose

  • Soohyung Park, MD, PhD

    assistant professor
    Korea university

    Disclosure(s): No financial relationships to disclose

  • John Tsung-Ying Tsai, MD, PhD

    Clinical Scientist

    Disclosure(s): No financial relationships to disclose

  • Hiroshi Tsunamoto, MD, PhD

    Research scholar
    Minneapolis Heart Institute Foundation, Minnesota, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Harold L. Dauerman, MD: medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
Robert W. Yeh, MD, MSc: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Life Sciences: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Elixir Medical Corporation: Consulting Fees (e.g., advisory boards) (Ongoing)
Ali Aldujeli, MD., MSc, PhD., MHEM, FESC, FSCAI, FHFA: No financial relationships to disclose
Michel T. Corban, MD: Philips Inc: Consulting Fees (e.g., advisory boards) (Ongoing)
Priyanka Ghosh, DO: No financial relationships to disclose
Joseph Ingrassia, MD: Inquis Medical: Consulting Fees (e.g., advisory boards) (Terminated, January 14, 2026); Jupiter Medical: Consulting Fees (e.g., advisory boards) (Terminated, January 14, 2026)
Arav Jhand, MD: No financial relationships to disclose
Katherine Lee Chuy, MD: Alnylam Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Pfizer: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Nidhi Madan, MD, MPH, FACC, FSCAI: No financial relationships to disclose
Soohyung Park, MD, PhD: No financial relationships to disclose
John Tsung-Ying Tsai, MD, PhD: No financial relationships to disclose
Hiroshi Tsunamoto, MD, PhD: No financial relationships to disclose